Women aged 65 and above are still at heightened risk of cervical cancer caused by human papillomavirus (HPV), suggest the ...

SOLUTION Group Bhd (SGB), through its wholly-owned subsidiary Solution Biologics Sdn Bhd (SOLBIO), has signed an exclusive ...

Biological E partners with China’s Recbio to produce REC603 a 9-valent HPV vaccine in India The collaboration aims to expand ...

Tips to persuade, and lead with empathy, in the dreaded vaccine conversation ...

Jiangsu Recbio Technology and Biological E. Limited are partnering for HPV9 vaccine. Recbio will transfer technology to ...

The US Secretary of Health and Human Services insists he will soon announce the "cause" of autism, but setting a fixed ...

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and ...

As fired and retired scientists rallied outside in the Atlanta heat, an advisory panel that Robert F. Kennedy Jr. handpicked ...

The Cancer Prevention and Research Institute of Texas has awarded nearly $3.4 million to UT Health San Antonio to advance ...

Interval between doses of HPV vaccine in 9- to 14-year-old females and males. Antibody responses were stronger with a longer interval (6 or 12 months) between the first two doses of HPV vaccine than a ...

The notable carcinogenic potential of the HPV POOL underscores the need for broader vaccine formulations. Adopting a nonavalent vaccine in future campaigns, expanding screening coverage, and ...

HPV vaccines offer the potential to decrease the incidence rate of HPV infection. Where secondary prevention programs (e.g., Pap screening or HPV testing) are not nationally organized, ...